Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Autoimmune Disorders

Free Subscription 10.11.2025 1 Ann Neurol 2 Intern Med 1 J Immunol 3 J Neuroimmunol 4 J Neurol 4 J Rheumatol 4 Kidney Int 6 Mult Scler 1 N Engl J Med 1 Neurologia (Engl Ed) 1 Neurology 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. ABRAMS AW, Waltz M, Casper TC, Aaen G, et al
   Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis.
   Ann Neurol. 2025 Nov 6. doi: 10.1002/ana.78086.
   PubMed         Abstract available
   
   

   
   Intern Med

2. MATSUO J, Namitome S, Hara Y, Terasaki T, et al
   Auto Immune Glial Fibrillary Acidic Protein Astrocytopathy Coexistent with Positivity for Anti-NH(2)-terminal of alpha-enolase Antibodies.
   Intern Med. 2025;64:3150-3154.
   PubMed         Abstract available
   
   
3. INOMATA H, Asatani S, Ikumi N, Uchikawa M, et al
   Malignancy-associated Multicentric Reticulohistocytosis Mimicking Dermatomyositis-like Features, with a Significant Ultrasound Finding.
   Intern Med. 2025 Nov 6. doi: 10.2169/internalmedicine.6032.
   PubMed         Abstract available
   
   

   
   J Immunol

4. DIAS DA ROCHA LIMA A, De Oliveira MG, Ferrari B, C Fonseca R, et al
   Dimethyl fumarate protects from experimental autoimmune encephalomyelitis by modulating colonic immune cells.
   J Immunol. 2025 Nov 1:vkaf289. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

5. DITLEVSEN REGEN E, Victor D, Hendrikx T
   Neoehrlichiosis in patients with multiple sclerosis in Halmstad, Sweden: A case series.
   J Neuroimmunol. 2025;410:578787.
   PubMed         Abstract available
   
   
6. DEMIR UNAL E
   A Neuroimmunological Axis between systemic autoimmunity and Parkinson's disease following long-COVID: A case series.
   J Neuroimmunol. 2025;410:578795.
   PubMed         Abstract available
   
   
7. DAGHLAS I, Pluvinage JV, Gill D
   Genetically reduced MTHFR activity confers protection against multiple sclerosis.
   J Neuroimmunol. 2025;410:578784.
   PubMed         Abstract available
   
   

   
   J Neurol

8. OZAKBAS S, Alizada S, Caliskan C, Simsek Y, et al
   Familial multiple sclerosis is associated with accelerated progression to secondary progressive phase: a retrospective single-center cohort study.
   J Neurol. 2025;272:749.
   PubMed         Abstract available
   
   
9. HUA LH, Brown B, Camacho E, Chinea AR, et al
   Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS study.
   J Neurol. 2025;272:725.
   PubMed         Abstract available
   
   
10. WASKOWIAK PT, de Jong BA, Uitdehaag BMJ, Myronenko A, et al
    Cognitive awareness in people with multiple sclerosis before and after neuropsychological assessment.
    J Neurol. 2025;272:748.
    PubMed         Abstract available
    
    
11. MATAS E, Bau L, Romero-Pinel L, Leon I, et al
    Benign multiple sclerosis and long-term outcomes after 30 years.
    J Neurol. 2025;272:747.
    PubMed         Abstract available
    
    

    
    J Rheumatol

12. MAYO-JUANATEY A, Castaneda S, Calvo-Rio V, Garijo-Bufort M, et al
    Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.
    J Rheumatol. 2025 Nov 5:jrheum.2025-0658.C1. doi: 10.3899/jrheum.2025-0658.
    PubMed         Abstract available
    
    
13. CHAN YN, Ardalan K, Lin L, Chen D, et al
    Congruence Between Child Self-Reported and Caregiver-Proxy Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0598. doi: 10.3899/jrheum.2025-0598.
    PubMed         Abstract available
    
    
14. CARLI L, Cavagna L, Cardelli C, Fattorini F, et al
    Anifrolumab therapy in Dermatomyositis: new insights from refractory patients.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0773. doi: 10.3899/jrheum.2025-0773.
    PubMed         Abstract available
    
    
15. BARONAITE HANSEN R, Faurschou M, Jacobsen S
    Comorbidity Development and Mortality During 10 Years of Follow-up in Danish Nationwide Cohort of 3,178 Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0015. doi: 10.3899/jrheum.2025-0015.
    PubMed         Abstract available
    
    

    
    Kidney Int

16. ALTUN B, Zhao G, Wang B, Mao X, et al
    Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T-cells.
    Kidney Int. 2025 Oct 31:S0085-2538(25)00855-5. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    
17. VILARDELL-VILA J, Jacobs-Cacha C, Martos-Guillami N, Motto AE, et al
    Sodium glucose cotransporter 2 inhibition does not improve active lupus nephritis in MRLlpr/lpr mice.
    Kidney Int. 2025 Oct 30:S0085-2538(25)00848-8. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    
18. NASR SH, Caza TN, Larsen CP, Storey A, et al
    Dual-Antigen Membranous Nephropathy.
    Kidney Int. 2025 Nov 4:S0085-2538(25)00862-2. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    
19. GLEESON PJ, Cogne M, Monteiro RC
    Mucin O-glycosylation and B-cell homing: a new bridge for the gut-kidney axis in IgA nephropathy?
    Kidney Int. 2025 Oct 20:S0085-2538(25)00784-7. doi: 10.1016/j.kint.2025.
    PubMed        
    
    

    
    Mult Scler

20. SIRIRATNAM P, Gosling S, Bhojak M, Griffiths M, et al
    A first report of progressive multifocal leukoencephalopathy in childhood-onset NMOSD.
    Mult Scler. 2025;31:1604-1607.
    PubMed         Abstract available
    
    
21. ELIAS S, Hardy TA, Khan A, Redgrave J, et al
    Balo's concentric sclerosis successfully treated with alemtuzumab: Long-term follow-up.
    Mult Scler. 2025;31:1600-1602.
    PubMed         Abstract available
    
    
22. YANG JH, Race J, Sumowski P, Jacques K, et al
    Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis.
    Mult Scler. 2025 Nov 6:13524585251386217. doi: 10.1177/13524585251386217.
    PubMed         Abstract available
    
    
23. VAN SCHEPENDOM J, Cutter G
    Lost in dichotomization: Preserving statistical power and sensitivity in MS cognitive research.
    Mult Scler. 2025;31:1513-1517.
    PubMed         Abstract available
    
    
24. SANDGREN S, Maceski AM, Benkert P, Einsiedler M, et al
    Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.
    Mult Scler. 2025;31:1531-1542.
    PubMed         Abstract available
    
    
25. SELMAJ KW, Steinman L, Comi G, Bar-Or A, et al
    Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Final analysis of the DAYBREAK open-label extension trial.
    Mult Scler. 2025;31:1557-1571.
    PubMed         Abstract available
    
    

    
    N Engl J Med

26. LAFAYETTE R, Barbour SJ, Brenner RM, Campbell KN, et al
    A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy.
    N Engl J Med. 2025 Nov 6. doi: 10.1056/NEJMoa2510198.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

27. RIVERO-DE-AGUILAR A, Mascarenas-Garcia M, Perez-Rios M, Llaneza-Gonzalez MA, et al
    Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis.
    Neurologia (Engl Ed). 2025;40:875-883.
    PubMed         Abstract available
    
    

    
    Neurology

28. KRIJNEN EA, Jelgerhuis J, Van Dam M, Bouman PM, et al
    Evolution of Cortical Lesions and Function-Specific Cognitive Decline in People With Multiple Sclerosis.
    Neurology. 2025;105:e214158.
    PubMed        
    
    

    
    PLoS One

29. YANG MK, Ha SJ, Sa HS
    Comparison of volumetric responses to different corticosteroid administration methods in IgG4-related ophthalmic disease.
    PLoS One. 2025;20:e0332392.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. KAPNICK SM, Gosselin EA, Tsai SJ, Oakes RS, et al
    Local control of T cell fate in lymph nodes safely and durably reverses myelin-driven autoimmunity.
    Proc Natl Acad Sci U S A. 2025;122:e2409563122.
    PubMed         Abstract available
    
    

    
    Thyroid

31. LIU L, Li C, Liu C, Qian T, et al
    Preliminary Evidence of Potential Association Between Exposure to Estriol-Containing Skincare Cosmetics Sold in China and Autoimmune Thyroid Disease.
    Thyroid. 2025 Oct 7. doi: 10.1177/10507256251382545.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.